Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

7 Dec 2017 07:00

RNS Number : 6168Y
MJ Gleeson PLC
07 December 2017
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

At the Annual General Meeting of MJ Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, convened for 11:30 am today in Sheffield, the Chairman, Dermot Gleeson, will state:

"Demand at Gleeson Homes remains strong with the forward order book at the end of November up more than 30% on last year.

"Land remains available at sensible prices and the pipeline remains strong. Gleeson Homes has a pipeline of 11,529 plots with a gross development value of £1.4 billion, of which 5,582 plots are owned and 5,947 are conditionally purchased.

"The division currently has 58 active sites, compared with 50 at this time last year and we expect the number of active sites to be approaching 70 by June 2018.

"The Government's Help to Buy scheme remains popular with 63% of our customers taking advantage of it so far this year while other buyers continue to be attracted by our own bespoke purchaser assistance packages.

"The division's increasing number of sales outlets, combined with very strong customer demand in all regions, good mortgage availability and attractive levels of affordability means that the outlook for the division remains very positive.

"The Board expects Gleeson Homes to record an increase in completions for the first half year to 31 December 2017 of more than 15% compared with the prior half year total of 451 units; and for the year to 30 June 2018 of approximately 20% compared with the prior year total of 1,013 units.

"Gleeson Strategic Land continues to experience strong demand for consented land in the first five months of the current financial year, completing the sale of two sites with planning permission for 50 plots and a 60-bed care home and is progressing sale negotiations on a further 10 sites.

"The division's land pipeline currently consists of 63 sites which have the potential to deliver approximately 21,455 plots. The portfolio includes 12 sites with planning permission.

"We expect Gleeson Strategic Land results for the full year June 2018 to be broadly in line with results for the prior financial year. Due to the timing of a site sale the division's results for the first half of the year may fall below those of the prior year. In this event, the second half is likely to be significantly stronger than the first.

"The Board, therefore, remains confident that the result for the full year to 30 June 2018 will be in line with expectations."

 

7 December 2017

This announcement contains inside information.

 

 

Enquiries:

MJ Gleeson plc

Tel: +44 1142 612 900

Jolyon Harrison

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

 

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Alex Laughton-Scott

Liberum

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMZMMGZNVKGNZM
Date   Source Headline
12th Feb 20254:14 pmRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSResults for the half year ended 31 December 2024
7th Feb 202511:51 amRNSDirector/PDMR Shareholding
14th Jan 20257:00 amRNSTrading Update & Notice of Results
7th Jan 20254:28 pmRNSDirector/PDMR Shareholding
9th Dec 20244:59 pmRNSDirector/PDMR Shareholding
3rd Dec 20243:50 pmRNSDirector/PDMR Shareholding
26th Nov 20243:34 pmRNSDirector/PDMR Shareholding
15th Nov 20242:08 pmRNSResult of AGM
15th Nov 20247:00 amRNSAGM Trading Update
7th Nov 20242:44 pmRNSDirector/PDMR Shareholding
30th Oct 202410:42 amRNSDirector/PDMR Shareholding
21st Oct 20247:00 amRNSNotice of AGM
18th Oct 20244:24 pmRNSDirector/PDMR Shareholding
18th Oct 20244:19 pmRNSDirector/PDMR Shareholding
9th Oct 20244:27 pmRNSDirector/PDMR Shareholding
4th Oct 202410:18 amRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSAudited results for the year ended 30 June 2024
9th Sep 202410:18 amRNSDirector/PDMR Shareholding
30th Aug 20247:00 amRNSTotal Voting Rights
7th Aug 20249:41 amRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSTotal Voting Rights
23rd Jul 20242:36 pmRNSDirector/PDMR Shareholding
23rd Jul 20241:53 pmRNSStandard form for notification of major holdings
11th Jul 20247:00 amRNSFY2024 Trading Update
8th Jul 20241:34 pmRNSDirector/PDMR Shareholding
8th Jul 20247:00 amRNSNotice of Trading Update
28th Jun 20247:00 amRNSTotal Voting Rights
6th Jun 20242:46 pmRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSTotal Voting Rights
15th May 20247:00 amRNSAppointment of Joint Corporate Broker
9th May 20249:41 amRNSDirector/PDMR Shareholding
30th Apr 20247:00 amRNSTotal Voting Rights
8th Apr 20243:41 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:28 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:28 pmRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20249:07 amRNSDirector/PDMR Shareholding
20th Mar 20241:45 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSTotal Voting Rights
26th Feb 20241:04 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSResults for the half year ended 31 December 2023
7th Feb 202411:34 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSTotal Voting Rights
9th Jan 202410:50 amRNSDirector/PDMR Shareholding
9th Jan 20247:00 amRNSTrading Update & Notice of Results
29th Dec 20237:00 amRNSTotal Voting Rights
15th Dec 20232:49 pmRNSRe Directorate External Appointments
6th Dec 20234:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.